Search

Your search keyword '"End Stage Liver Disease microbiology"' showing total 31 results

Search Constraints

Start Over You searched for: Descriptor "End Stage Liver Disease microbiology" Remove constraint Descriptor: "End Stage Liver Disease microbiology"
31 results on '"End Stage Liver Disease microbiology"'

Search Results

1. The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications.

2. Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources

3. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases.

4. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease.

5. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.

6. Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.

7. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.

9. A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD.

10. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.

11. Multidrug-Resistant Bacteria and Disease Progression in Patients with End-Stage Liver Disease and after Liver Transplantation.

12. Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A Review.

13. Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota.

14. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

15. Alterations in gut microbial function following liver transplant.

16. A High Portal Venous Pressure Gradient Increases Gut-Related Bacteremia and Consequent Early Mortality After Living Donor Liver Transplantation.

17. [End-stage liver disease and invasive fungal infection].

18. Role of Candida Albicans Germ Tube Antibody in Diagnosis of Invasive Candidiasis in End Stage Liver Disease Patients.

19. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.

20. Gut microbiota of liver transplantation recipients.

21. Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease.

22. The relevance of intestinal dysbiosis in liver transplant candidates.

23. Comparing the factors correlated with tuberculosis-specific and non-tuberculosis-specific deaths in different age groups among tuberculosis-related deaths in Taiwan.

24. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes.

25. Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?

26. Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion.

27. Altered profile of human gut microbiome is associated with cirrhosis and its complications.

28. Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.

29. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?

30. [Hepatic encephalopathy and liver transplantation].

31. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.